Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC

Obesity represents a well-known risk factor for renal cell carcinoma development. Several studies evaluated the relationship between obesity and outcome in patients with non-metastatic and metastatic renal cell carcinoma using different parameters such as BMI, visceral fat area and s.c. fat area. These studies suggest that obesity is associated with a better prognosis in renal cell carcinoma patients. This phenomenon is called obesity paradox and it was found in other diseases in which obesity rep resents an established risk factor such as heart failure, diabetes, atrial fibrillation, hypertension and coronary heart disease. The purpose of this review is to analyze the mec hanisms by which obesity increases the risk of renal cell carcinoma development, to describe the evidence available to date about the link obesity-outcome and to evaluate the mech anisms to explain this apparently paradoxical relationship.

Automated summary

Obesity is a well-known risk factor for renal cell carcinoma development, but studies have found that it may actually be associated with a better prognosis in patients with this type of cancer, a phenomenon known as the obesity paradox. The purpose of research in this area is to better understand the mechanisms behind this paradoxical relationship.